Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein N2 (FOXN2) is a member of the forkhead box (FOX) family of transcription factors characterized by a winged-helix DNA-binding domain[1][8]. It acts as a transcriptional regulator, including modulating the response elements in the long terminal repeat (LTR) of human T-cell leukemia virus (HTLV)[2][3]. FOXN2 functions as a tumor suppressor, regulating cell proliferation, migration, invasion, and therapeutic response in various cancer types; reduced expression or degradation of FOXN2 is linked with enhanced cancer aggressiveness and poorer patient outcomes. It is also implicated in transcriptional regulation of genes involved with immune and tissue-specific developmental processes[1][2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein N2 (FOXN2).